Champions Oncology, Inc.
Champions Oncology, Inc. (NASDAQ: CSBR) is trading at $4.81, about ₹462 at today's USD/INR rate, as of 25 Sep 2026, 1:03 PM ET, down 2.83% today. Indian residents can buy Champions Oncology from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
$4.80
Today's high
$4.92
52 week low
$4.59
52 week high
$8.31
CSBR opened at $4.81, closed previously at $4.95, and has traded between $4.59 and $8.31 over the past 52 weeks.
About
Champions Oncology, Inc. is dedicated to developing and commercializing cutting-edge technological products and services designed to personalize cancer treatment and streamline the development of oncology drugs across the United States. At the heart of its offerings is the Tumorgraft Technology Platform, an innovative approach that facilitates individualized cancer care by implanting human tumors into immune-deficient mice. Utilizing this proprietary platform, the company not only delivers personalized cancer solutions directly but also provides Translational Oncology Solutions, supporting pharmaceutical and biotechnology companies through their drug development lifecycle. Additionally, Champions Oncology offers Lumin Bioinformatics, a comprehensive software platform and data tool filled with insights from research services and clinical studies, accessible through annual subscriptions. The company distributes its offerings through various channels, including online platforms, word-of-mouth referrals, and a dedicated sales team, reaching both patients and healthcare professionals. Established in 1985, Champions Oncology, Inc. is based in Hackensack, New Jersey, and was formerly known as Champions Biotechnology, Inc. until its name change in April 2011.
Key statistics
Avg. volume
10.04K
Market cap
$66.83M
P/E Ratio
-60.89
Price-to-sales ratio
1.10
Enterprise value
$73.44M
Free cash flow yield
-9.18%
Debt-to-equity ratio
2.82
Return on equity
-27.88%
ROIC
-6.75%
Beta
0.40
Dividend yield
0.00%
Last dividend
$0.00
Financial overview
Revenue
$59.42M
Earnings per share
-$0.08
Free cash flow
-$5.04M
Net profit margin
-1.87%
Gross margin
49.30%
EBITDA
$448.00K
Revenue growth
4.36%
Similar securities
This is not an investment recommendation
How to buy Champions Oncology from India
Indian residents can buy Champions Oncology shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.
Search for Champions Oncology and place an order
Find Champions Oncology by name or by its ticker, CSBR, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. Champions Oncology trades 7:00 pm – 1:30 am IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Champions Oncology position in USD and INR. Champions Oncology pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in Champions Oncology from India
Trading and taxes when buying Champions Oncology from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm ET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneChampions Oncology does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
- US estate tax
- May applyUS-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons.US estate tax calculator
Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
FAQs
Can Indian residents buy Champions Oncology stock?
Yes. Champions Oncology (CSBR) has been listed on NASDAQ since 2007, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
How much does one Champions Oncology share cost in rupees?
One Champions Oncology share is $4.81 — about ₹462 at a USD/INR rate of 96.02 on 24 Sep 2026. Both the Champions Oncology price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Champions Oncology from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
Can I buy whole shares of Champions Oncology?
Yes. One Champions Oncology share is $4.81, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in Champions Oncology.
How are gains on Champions Oncology shares taxed in India?
The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Champions Oncology price. Paasa issues a capital-gains statement for your return.
Does Champions Oncology pay a dividend?
No. Champions Oncology does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade Champions Oncology from India?
NASDAQ trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.
Is there estate or inheritance tax on Champions Oncology shares held from India?
US-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons. It applies to your overall holdings in that jurisdiction rather than to any one position. Paasa's US estate tax calculator shows the exposure for a given portfolio value.
Do I have to declare Champions Oncology shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Champions Oncology holding, its cost and its closing value.
How do I sell Champions Oncology and bring the money back to India?
You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.